{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:42:53Z","timestamp":1790026973056,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier","isbn-type":[{"value":"9780128155578","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.apcsb.2018.10.002","type":"book-chapter","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T22:27:07Z","timestamp":1543616827000},"page":"315-339","source":"Crossref","is-referenced-by-count":33,"title":["A comparative computational approach toward pharmacological chaperones (NN-DNJ and ambroxol) on N370S and L444P mutations causing Gaucher's disease"],"prefix":"10.1016","author":[{"given":"D.","family":"Thirumal Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharada","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Priyadharshini","family":"Christy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Siva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftikhar Aslam","family":"Tayubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"George Priya Doss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.apcsb.2018.10.002_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High-performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jtbi.2017.10.028","article-title":"Substitution impact of highly conserved arginine residue at position 75 in GJB1 gene in association with X-linked Charcot\u2013Marie-tooth disease: A computational study","volume":"437","author":"Agrahari","year":"2018","journal-title":"Journal of Theoretical Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.10.002_bb0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1681\/ASN.2005080854","article-title":"Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus","volume":"17","author":"Bernier","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"451","key":"10.1016\/bs.apcsb.2018.10.002_bb9000","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/08035320600619039","article-title":"Gaucher disease: Multiple lessons from a single gene disorder","volume":"95","author":"Beutler","year":"2006","journal-title":"Acta Paediatrica"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.10.002_bb9005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4103\/2230-8210.83402","article-title":"Gaucher's disease","volume":"15","author":"Bohra","year":"2011","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1090","article-title":"Discovering genotypes underlying human phenotypes: Past successes for mendelian disease, future approaches for complex disease","volume":"33","author":"Botstein","year":"2003","journal-title":"Nature Genetics"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.10.002_bb0030","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1021\/jm301557k","article-title":"Pharmacological chaperones as therapeutics for lysosomal storage diseases","volume":"56","author":"Boyd","year":"2013","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0021-9258(18)97611-8","article-title":"The metabolism of glucocerebrosides. I. Purification and properties of a glucocerebroside-cleaving enzyme from spleen tissue","volume":"240","author":"Brady","year":"1965","journal-title":"The Journal of Biological Chemistry"},{"issue":"15","key":"10.1016\/bs.apcsb.2018.10.002_bb0040","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1021\/jm3006178","article-title":"Conformationally-locked N-glycosides with selective \u03b2-glucosidase inhibitory activity: Identification of a new non-iminosugar-type pharmacological chaperone for Gaucher disease","volume":"55","author":"Castilla","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"issue":"9","key":"10.1016\/bs.apcsb.2018.10.002_bb0045","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/cbic.200600217","article-title":"Design and synthesis of highly potent and selective pharmacological chaperones for the treatment of Gaucher's disease","volume":"7","author":"Compain","year":"2006","journal-title":"Chembiochem"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.10.002_bb0050","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3390\/ijms17071065","article-title":"Less is more: Substrate reduction therapy for lysosomal storage disorders","volume":"17","author":"Coutinho","year":"2016","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0055","first-page":"299","article-title":"Gaucher disease: Clinical profile and therapeutic developments","volume":"4","author":"Cox","year":"2010","journal-title":"Biologics: Targets & Therapy"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1399-0004.2010.01381.x","article-title":"Gaucher disease: Frequency of the N370S mutation in the Greek population","volume":"78","author":"Dimitriou","year":"2010","journal-title":"Clinical Genetics"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmg.2008.02.004","article-title":"Molecular analysis of Turkish Gaucher disease patients: Identification of novel mutations in glucocerebrosidase (GBA) gene","volume":"51","author":"Emre","year":"2008","journal-title":"European Journal of Medical Genetics"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0075","first-page":"895831","article-title":"Integrating in silico prediction methods, molecular docking, and molecular dynamics simulation to predict the impact of ALK missense mutations in structural perspective","volume":"2014","author":"George Priya Doss","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0080","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1038\/srep05868","article-title":"Structural signature of the G719S-T790M double mutation in the EGFR kinase domain and its response to inhibitors","volume":"4","author":"George Priya Doss","year":"2014","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0085","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1039\/C3MB70427K","article-title":"In silico profiling and structural insights of missense mutations in RET protein kinase domain by molecular dynamics and docking approach","volume":"10","author":"GeorgePriya Doss","year":"2014","journal-title":"Molecular BioSystems"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.10.002_bb0090","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1136\/jmg.2004.028019","article-title":"Divergent phenotypes in Gaucher disease implicate the role of modifiers","volume":"42","author":"Goker-Alpan","year":"2005","journal-title":"Journal of Medical Genetics"},{"issue":"15","key":"10.1016\/bs.apcsb.2018.10.002_bb9010","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0888-7543(89)90319-4","article-title":"The human glucocerebrosidase gene and pseudogene: Structure and evolution","volume":"4","author":"Horowitz","year":"1989","journal-title":"Genomics"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Human Mutation"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.10.002_bb0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2183\/pjab.88.18","article-title":"Pharmacological chaperone therapy for Fabry disease","volume":"88","author":"Ishii","year":"2012","journal-title":"Proceedings of the Japan Academy. Series B, Physical and Biological Sciences"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/bs.apcsb.2015.09.008","article-title":"Investigating the inhibitory effect of Wortmannin in the hotspot mutation at codon 1047 of PIK3CA kinase domain: A molecular docking and molecular dynamics approach","volume":"102","author":"Kumar","year":"2016","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"issue":"1","key":"10.1016\/bs.apcsb.2018.10.002_bb0115","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddq454","article-title":"Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease","volume":"20","author":"Lesage","year":"2011","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0120","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/bi9002265","article-title":"Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability","volume":"48","author":"Lieberman","year":"2009","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.10.002_bb0125","first-page":"701","article-title":"Radius of gyration is indicator of compactness of protein structure","volume":"42","author":"Lobanov","year":"2008","journal-title":"Molekuliarnaia Biologiia (Mosk)"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.10.002_bb0130","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1021\/ct200196m","article-title":"An automated force field topology builder (ATB) and repository: Version 1.0","volume":"7","author":"Malde","year":"2011","journal-title":"Journal of Chemical Theory and Computation"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0135","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneurol.2007.68","article-title":"Glucocerebrosidase gene mutations: A risk factor for Lewy body disorders","volume":"65","author":"Mata","year":"2008","journal-title":"Archives of Neurology"},{"issue":"9","key":"10.1016\/bs.apcsb.2018.10.002_bb0140","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/qjmed\/hcq117","article-title":"Fabry disease: A review of current management strategies","volume":"103","author":"Mehta","year":"2010","journal-title":"QJM"},{"issue":"7","key":"10.1016\/bs.apcsb.2018.10.002_bb0145","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/jama.2015.459","article-title":"Effect of oral eliglustat on splenomegaly in patients with Gaucher disease type 1The ENGAGE randomized clinical trial","volume":"313","author":"Mistry","year":"2015","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20043","article-title":"Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: pathogenic changes and \u2018modifier\u2019 polymorphisms","volume":"23","author":"Montfort","year":"2004","journal-title":"Human Mutation"},{"issue":"16","key":"10.1016\/bs.apcsb.2018.10.002_bb0155","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"Journal of Computational Chemistry"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0160","article-title":"Mechanism of artemisinin resistance for malaria PfATP6 L263 mutations and discovering potential antimalarials: An integrated computational approach","volume":"6","author":"Nagasundaram","year":"2016","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1016\/bs.apcsb.2018.10.002_bb0165","article-title":"Analyzing the effect of mutation on protein function and discovering potential inhibitors of CDK4: Molecular modeling and dynamics studies","volume":"10","author":"Nagasundaram","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.10.002_bb0170","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/acn3.292","article-title":"Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study","volume":"3","author":"Narita","year":"2016","journal-title":"Annals of Clinical Translational Neurology"},{"issue":"9","key":"10.1016\/bs.apcsb.2018.10.002_bb0175","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type 1 Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"issue":"13","key":"10.1016\/bs.apcsb.2018.10.002_bb0180","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/jcc.20090","article-title":"A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6","volume":"25","author":"Oostenbrink","year":"2004","journal-title":"Journal of Computational Chemistry"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.10.002_bb0185","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/pro.2449","article-title":"Contribution of hydrogen bonds to protein stability","volume":"23","author":"Pace","year":"2014","journal-title":"Protein Science"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.10.002_bb0190","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/mt.2009.53","article-title":"The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts","volume":"17","author":"Porto","year":"2009","journal-title":"Molecular Therapy"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.10.002_bb9015","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10545-006-0363-3","article-title":"Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann\u2013Pick disease type A\/B and C","volume":"29","author":"Ries","year":"2006","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"15","key":"10.1016\/bs.apcsb.2018.10.002_bb0195","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCULATIONAHA.109.914820","article-title":"Pharmacogenomics: The genetics of variable drug responses","volume":"123","author":"Roden","year":"2011","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/bs.apcsb.2018.10.002_bb0200","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrm3658","article-title":"Chaperone machines for protein folding, unfolding and disaggregation","volume":"14","author":"Saibil","year":"2013","journal-title":"Nature Reviews: Molecular Cell Biology"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0205","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/ejhg.2012.105","article-title":"A germline or de novo mutation in two families with Gaucher disease: Implications for recessive disorders","volume":"21","author":"Saranjam","year":"2013","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0210","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","article-title":"Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles","volume":"12","author":"Sawkar","year":"2005","journal-title":"Chemistry & Biology"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0215","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0065-3101(24)00049-5","article-title":"New perspectives in type 2 Gaucher disease","volume":"44","author":"Sidransky","year":"1997","journal-title":"Advances in Pediatrics"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/humu.1380030105","article-title":"DNA mutational analysis of type 1 and type 3 Gaucher patients: How well do mutations predict phenotype?","volume":"3","author":"Sidransky","year":"1994","journal-title":"Human Mutation"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0225","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1016\/bs.apcsb.2018.10.002_bb0230","first-page":"1","article-title":"Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach","volume":"12","author":"Sneha","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0235","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-018-0285-4","article-title":"Impact of missense mutations in survival motor neuron protein (SMN1) leading to spinal muscular atrophy (SMA): A computational approach","author":"Sneha","year":"2018","journal-title":"Metabolic Brain Disease"},{"issue":"6","key":"10.1016\/bs.apcsb.2018.10.002_bb0240","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1074\/jbc.M111.280016","article-title":"Ex vivo and in vivo effects of isofagomine on acid \u03b2-glucosidase variants and substrate levels in Gaucher disease","volume":"287","author":"Sun","year":"2012","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0245","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-018-0286-3","article-title":"Computational modelling approaches as a potential platform to understand the molecular genetics association between Parkinson's and Gaucher diseases","author":"Thirumal Kumar","year":"2018","journal-title":"Metabolic Brain Disease"},{"issue":"12","key":"10.1016\/bs.apcsb.2018.10.002_bb0250","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1080\/07391102.2016.1231082","article-title":"Role of E542 and E545 missense mutations of PIK3CA in breast cancer: A comparative computational approach","volume":"35","author":"Thirumal Kumar","year":"2017","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"issue":"5","key":"10.1016\/bs.apcsb.2018.10.002_bb0255","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1080\/07391102.2016.1166456","article-title":"Influence of V54 M mutation in Giant muscle protein titin: A computational screening and molecular dynamics approach","volume":"35","author":"Thirumal Kumar","year":"2016","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0260","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-018-0278-3","article-title":"Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2","author":"Thirumal Kumar","year":"2018","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0265","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1002\/jcb.26064","article-title":"A molecular docking and dynamics approach to screen potent inhibitors against Fosfomycin resistant enzyme in clinical Klebsiella pneumoniae","volume":"118","author":"Thirumal Kumar","year":"2017","journal-title":"Journal of Cellular Biochemistry"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.10.002_bb0270","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/adt.2011.0370","article-title":"Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders","volume":"9","author":"Valenzano","year":"2011","journal-title":"Assay and Drug Development Technologies"},{"issue":"3","key":"10.1016\/bs.apcsb.2018.10.002_bb0275","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11910-010-0102-x","article-title":"The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders","volume":"10","author":"Velayati","year":"2010","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0280","first-page":"433","article-title":"The role of hydrogen-bonds in drug binding","volume":"289","author":"Wade","year":"1989","journal-title":"Progress in Clinical and Biological Research"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0285","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jmg.30.4.280","article-title":"Gaucher's disease in the United Kingdom: Screening non-Jewish patients for the two common mutations","volume":"30","author":"Walley","year":"1993","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0290","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(89)90536-9","article-title":"Prediction of severity of Gaucher's disease by identification of mutations at DNA level","volume":"334","author":"Zimran","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003440","article-title":"PredictSNP: Robust and accurate consensus classifier for prediction of disease-related mutations","volume":"10","author":"Bendl","year":"2014","journal-title":"PLoS Computational Biology"},{"issue":"Suppl. 2","key":"10.1016\/bs.apcsb.2018.10.002_bb0300","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2105-14-S4-S5","article-title":"iStable: Off-the-shelf predictor integration for predicting protein stability changes","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"Database issue","key":"10.1016\/bs.apcsb.2018.10.002_bb0305","doi-asserted-by":"crossref","first-page":"D935","DOI":"10.1093\/nar\/gkr996","article-title":"SNPeffect 4.0: On-line prediction of molecular and structural effects of protein-coding variants","volume":"40","author":"De Baets","year":"2012","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0310","series-title":"De l\u2019epithelioma primitif de la rate, hypertrophie idiopathique de la rate sans leucemie","author":"Gaucher","year":"2003"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0315","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/bioinformatics\/19.1.163","article-title":"ConSurf: Identification of functional regions in proteins by surface-mapping of phylogenetic information","volume":"19","author":"Glaser","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/bs.apcsb.2018.10.002_bb0320","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Molecular Chaperones in Human Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162318300646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162318300646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T07:51:03Z","timestamp":1775289063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162318300646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128155578"],"references-count":67,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2018.10.002","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}